Phil Lee

Phil Lee

Auto-generated profile, based on publicly available information

Phil Lee

Department of Radiology University of Kansas Medical Center Kansas City Kansas USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2021 in NMR in Biomedicine
Verified
Journal Article
Open access
PDF file
ALAlexander Lin
Alexander Lin
OAOvidiu Andronesi
Ovidiu Andronesi
Wolfgang BognerWolfgang Bogner
Wolfgang Bogner
ICIn‐Young Choi
In‐Young Choi
ECEduardo Coello
Eduardo Coello
ESExperts' Working Group on Reporting Standards for MR Spectroscopy
Experts' Working Group on Reporting Standards for MR Spectroscopy
The translation of MRS to clinical practice has been impeded by the lack of technical standardization. There are multiple methods of acquisition, post‐processing, and analysis whose details greatly impact the interpretation of the results. These details are often not fully reported, making it difficult to assess MRS studies on a standardized basis. This hampers the reviewing of manuscripts, limits the reproducibility of study results, and complicates meta‐analysis of the literature. In this paper a consensus group of MRS experts provides minimum guidelines for the reporting of MRS methods and results, including the standardized description of MRS hardware, data acquisition, analysis, and quality assessment. This consensus statement describes each of these requirements in detail and includes a checklist to assist authors and journal reviewers and to provide a practical way for journal editors to ensure that MRS studies are reported in full.

4 December 2012 in NMR in Biomedicine
Verified
Journal Article
Closed access
PDF file
SKSeong-Gi Kim
Seong-Gi Kim
NHNoam Harel
Noam Harel
TJTao Jin
Tao Jin
TKTae Kim
Tae Kim
PLPhil Lee
Phil Lee
FZFuqiang Zhao
Fuqiang Zhao

1 September 2011 in Experimental Neurology
Verified
Journal Article
Closed access
JMJ.K. Morris
J.K. Morris
GBG.L. Bomhoff
G.L. Bomhoff
BGB.K. Gorres
B.K. Gorres
VDV.A. Davis
V.A. Davis
JKJ. Kim
J. Kim
JSJohn A Stanford
John A Stanford

18 September 2020 in NMR in Biomedicine
Verified
Journal Article
Closed access
PDF file
ICIn‐Young Choi
In‐Young Choi
OAOvidiu Andronesi
Ovidiu Andronesi
PBPeter Barker
Peter Barker
Wolfgang BognerWolfgang Bogner
Wolfgang Bogner
RERichard A. E. Edden
Richard A. E. Edden
RGRobin A. de Graaf
Robin A. de Graaf

15 August 2012 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Open access
JHJanna L Harris
Janna L Harris
HYHung-Wen Yeh
Hung-Wen Yeh
ICIn-Young Choi
In-Young Choi
PLPhil Lee
Phil Lee
NBNancy E Berman
Nancy E Berman
WBWilliam M Brooks
William M Brooks
Specific neurochemicals measured with proton magnetic resonance spectroscopy (1H-MRS) may serve as biomarkers of pathological mechanism in the brain. We used high field in vivo1H-MRS to measure a detailed neurochemical profile after experimental traumatic brain injury (TBI) in rats. We characterized neurochemical changes in the contused cortex and the normal-appearing perilesional hippocampus over a time course from 1 hour to 2 weeks after injury. We found significant changes in 19 out of 20 neurochemicals in the cortex, and 9 out of 20 neurochemicals in the hippocampus. These changes provide evidence of altered cellular metabolic status after TBI, with specific compounds proposed to reflect edema, excitotoxicity, neuronal and glial integrity, mitochondrial status and bioenergetics, oxidative stress, inflammation, and cell membrane disruption. Our results support the utility of 1H-MRS for monitoring cellular mechanisms of TBI pathology in animal models, and the potential of this approach for preclinical evaluation of novel therapies.

4 October 2010 in Multiple Sclerosis Journal
Verified
Journal Article
Closed access
PDF file
ICI-Y Choi
I-Y Choi
SLS-P Lee
S-P Lee
DDD R Denney
D R Denney
SLSg Lynch
Sg Lynch
Background: Disability levels for patients with secondary progressive multiple sclerosis (SPMS) often worsen despite a stable MRI T2 lesion burden. The presence of oxidative stress in the absence of measurable inflammation could help explain this phenomenon. In this study, the assessment of an in vivo marker of oxidative stress, cerebral glutathione (GSH), using magnetic resonance chemical shift imaging (CSI) is described, and GSH levels were compared in patients with SPMS and healthy controls. Objective: To assess whether GSH, a key antioxidant in the brain, is lower in the SPMS patients compared to matched controls. Methods: Seventeen patients with SPMS (Expanded Disability Status Scale = 4.0–7.0; length of MS diagnosis = 19.4 ± 7 years) and 17 age- and gender-matched healthy controls were studied. GSH levels were measured in the fronto-parietal regions of the brain using a specially designed magnetic resonance spectroscopy technique, CSI of GSH, at 3T. Results: The levels of GSH were lower for SPMS patients than for controls, the largest reduction (18.5%) being in the frontal region ( p = 0.001). Conclusion: The lower GSH levels in these patients indicate the presence of oxidative stress in SPMS. This process could be at least partially responsible for ongoing functional decline in SPMS.